Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EP... (enhance our customer centric focus enabl...)

Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.

Date:10/23/2007

enhance our customer centric focus, enabling us to

deliver another quarter of strong sales performance. Our Research

Essentials unit delivered above target sales growth for the second

successive quarter, and Research Specialties has now achieved better

than expected growth in each of the last five quarters. Research

Biotech had its strongest quarterly gain in 2007, supporting our

confidence in the activities we've added to boost sales growth for

this unit and our earlier forecast for organic growth of 6% over the

second half of 2007. And SAFC turned in another strong quarterly

performance with contributions from both its core businesses and the

Epichem acquisition that is enhancing success in our Hitech business;

-- Increasing reported and adjusted sales growth in CAPLA (Canada, Asia

Pacific and Latin America) markets by 21.1% and 12.1%, respectively,

in Q3 2007. Reported quarterly sales growth in our primary focus

markets of Brazil, China and India remained robust and we recently

announced plans to increase our presence in China with the

construction of our first manufacturing site in that country;

-- Boosting sales from web-based ordering yet again through our

industry-leading web site to 41% of worldwide Q3 2007 Research based

sales, one full quarter ahead of our full year 2007 goal of 40%.

Average daily visits to our website neared the 100,000 level during

the final month of the quarter;

-- Continuing our commitment to process improvement with more than

$5 million in additional savings during Q3 to yield $12 million in

year-to-date benefits as we seek to meet or beat our goal of

$15 million in savings for the full year; and

-- Adding exciting new capabilities to our Research Biotech business by

acquiring
'/>"/>

Post Your Comments:

Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EP...(enhance our customer centric focus enabl...)